SCIOTO BIOSCIENCES, INC.
SB-121, a biofilm of Lactobacillus reuteri bacteria adhered to porous microspheres for prevention of necrotizing enterocolitis in premature infants
- Sector
- Biotech
- Headquarters
- INDIANOPOLIS, IN
- Founded
- 2017
- Latest Form D
- $1.8M, May 2018
- Total capital
- $4.1M
- Federal grants
- $2.3M
- 2 awards · 2019–2020
- Rank in peer group#478 of 514
- Private capital raised
- $1.8M
- 1 Form D · last May 2018
- 102 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · A Novel Probiotic Platform to Treat Necrotizing Enterocolitis$1.1M
- Federal grantHealth and Human S · Phase II · A Novel Probiotic Platform to Treat Necrotizing Enterocolitis$1.2M
- Private capital raisedForm D · SEC · 1st filing$1.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- James SchulzExecutive Officer, DirectorNamed in SEC Form D filings
- Joseph TrebleyExecutive Officer, DirectorNamed in SEC Form D filings
- Kevin MeyerExecutive OfficerNamed in SEC Form D filings
- Mark HeimanExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingMethods For Treating Or Ameliorating Autism And Related DisordersUSPTOApplication 17792329
- PendingMethods For Treating Or Ameliorating Autism And Related DisordersUSPTOApplication PCTUS2021013280
- PendingMethods For Mitigating Antibiotic AdministrationUSPTOApplication 62960331
Show all 4 patent records
- Methods For Treating Or Ameliorating Autism And Related DisordersMar 9, 2023 · Application 17792329Pending
- Methods For Treating Or Ameliorating Autism And Related DisordersApplication PCTUS2021013280Pending
- Methods For Mitigating Antibiotic AdministrationApplication 62960331Pending
- Methods For Decreasing Food IntakeApplication 62960328Pending
Related companies, and why
- GELBCHEM, LLCSimilar federal contract value in Biotech · null in contracts
- I-CORDIS, LLCSimilar federal contract value in Biotech · null in contracts
- Path Biotech, LLCSimilar federal contract value in Biotech · null in contracts
- Thetis Pharmaceuticals LLCSimilar federal contract value in Biotech · null in contracts
- INVENIO THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- TING THERAPEUTICS LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .